Antenatal screening for thyroid dysfunction: pre-term birth, low birth-weight, and growth restriction

References

• Dhaifalah I, Salek T, Langova D, et al. Routine first trimester screening for maternal thyroid disease. J Fetal Med. 2017;4(1):1–6. doi:10.1007/s40556-017-0112-8.
   Google Scholar
• Dhaifalah I, Havalova J, Langova D, et al. Women with positive first trimester thyroid disease screening results. J Fetal Med. 2019;6(3):123–126. doi:10.1007/s40556-019-00218-6.
   Web of Science ®Google Scholar
• Sheehan PM, Nankervis A, Araujo Júnior E, et al. Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(11):4325–4331. doi:10.1210/jc.2015-3074.
   PubMed Web of Science ®Google Scholar
• Nazarpour S, Amiri M, Bidhendi Yarandi R, et al. Maternal subclinical hyperthyroidism and adverse pregnancy outcomes: a systematic review and meta-analysis of observational studies. Int J Endocrinol Metab. 2022;20(3):e120949. doi:10.5812/ijem-120949.
   PubMed Web of Science ®Google Scholar
• Spencer L, Bubner T, Bain E, et al. Screening and subsequent management for thyroid dysfunction pre-pregnancy and during pregnancy for improving maternal and infant health. Cochrane Database Syst Rev. 2015;2015(9):CD011263. (doi:10.1002/14651858.CD011263.pub2.
   PubMedGoogle Scholar
• Negro R, Schwartz A, Gismondi R, et al. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. J Clin Endocrinol Metab. 2010;95(4):1699–1707. doi:10.1210/jc.2009-2009.
   PubMed Web of Science ®Google Scholar
• Lazarus JH, Bestwick JP, Channon S, et al. Antenatal thyroid screening and childhood cognitive function. N Engl J Med. 2012;366(6):493–501. doi:10.1056/NEJMoa1106104.
   PubMed Web of Science ®Google Scholar
• Yamamoto JM, Benham JL, Nerenberg KA, et al. Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy: a systematic review and meta-analysis of randomized controlled trials. BMJ Open. 2018;8(9):e022837. doi:10.1136/bmjopen-2018-022837.
   PubMed Web of Science ®Google Scholar
• Bein M, Yu OHY, Grandi SM, et al. Levothyroxine and the risk of adverse pregnancy outcomes in women with subclinical hypothyroidism: a systematic review and meta-analysis. BMC Endocr Disord. 2021;21(1):34. doi:10.1186/s12902-021-00699-5.
   PubMed Web of Science ®Google Scholar
• Dhaifalah I, Salek T, Langova D, et al. Incorporating thyroid markers in Down’s syndrome screening protocols. Prenat Diagn. 2017;37(5):510–514. doi:10.1002/pd.5047.
   PubMed Web of Science ®Google Scholar
• Nicolaides KH, Wright D, Syngelaki A, et al. Fetal medicine foundation fetal and neonatal population weight charts. Ultrasound Obstet Gynecol. 2018;52(1):44–51. doi:10.1002/uog.19073.
   PubMed Web of Science ®Google Scholar
• Casey BM, Thom EA, Peaceman AM, et al. Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy. N Engl J Med. 2017;376(9):815–825. doi:10.1056/NEJMoa1606205.
   PubMed Web of Science ®Google Scholar
• van Dijk MM, Vissenberg R, Fliers E, et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(5):322–329. doi:10.1016/S2213-8587(22)00045-6.
   PubMed Web of Science ®Google Scholar
• Verhagen NJE, Gowachirapant S, Winichagoon P, et al. Iodine supplementation in mildly iodine-deficient pregnant women does not improve maternal thyroid function or child development: a secondary analysis of a randomized controlled trial. Front Endocrinol. 2020;11:572984. doi:10.3389/fendo.2020.572984.
   PubMed Web of Science ®Google Scholar
• Mercer BM, Goldenberg RL, Moawad AH, et al. The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol. 1999;181(5 Pt 1):1216–1221. doi:10.1016/s0002-9378(99)70111-0.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Rosas-Bermúdez A, Kafury-Goeta AC. Birth spacing and risk of adverse perinatal outcomes: a metaanalysis. JAMA. 2006;295(15):1809–1823. doi:10.1001/jama.295.15.1809.
   PubMed Web of Science ®Google Scholar
• Arndt J, Vess M, Cox CR, et al. Medical, psychosocial, and behavioral risk factors do not explain the increased risk for low birth weight among black women. Med Decis Making. 2009;29(2):175–181. doi:10.1016/s0002-9378(96)70048-0.
   PubMedGoogle Scholar
• Glover AV, Manuck TA. Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: a review. Semin Fetal Neonatal Med. 2018;23(2):126–132. doi:10.1016/j.siny.2017.11.007.
   PubMed Web of Science ®Google Scholar
• De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–2565. Erratum in: J Clin Endocrinol Metab. 2021;106(6):e2461. doi:10.1210/jc.2011-2803.
   PubMed Web of Science ®Google Scholar